HYPE has declined 3.3% in 24 hours to $45.13 despite Hyperliquid platform recording historic $18.99 billion daily perpetuals ...

Hanoi is implementing a series of breakthrough plans, ranging from attracting investment and developing high-tech products to ...

In July 2025, global markets have been navigating a complex landscape marked by new U.S. tariff announcements and mixed economic signals, with the Nasdaq Composite Index showing resilience amidst ...

In a recent market update, Goldman Sachs raised its year-end forecast for the S&P 500 (SPX) to 6,900 by year-end, up from a ...

On Tuesday, 150 stocks reached 52-week highs while 36 hit lows, as the Sensex rose over 317 points. Key sectors driving ...

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

Meanwhile, if you buy the shares while they're down, you will have gotten in on the stock for a bargain -- and can maximize ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added the stock to its ...

IPO stocks like Circle and CoreWeave have highlighted a revived U.S. IPO market. But can the rebound in valuations last?

Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed ...

The first half of 2025 was a roller-coaster ride for investors with the broader market surging to new highs at the beginning ...